This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Andrassy, M. Articles by Bierhaus, A. PubMed PubMed Citation Articles by Andrassy, M. Articles by Bierhaus, A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH Related Collections Electrophysiology Animal models of human disease Cell signalling/signal transduction Ischemic biology - basic studies Related Article

(Circulation. 2008;117:3216-3226.)
© 2008 American Heart Association, Inc.

Molecular Cardiology

High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart

Martin Andrassy, MD; Hans C. Volz, MD; John C. Igwe, PhD; Benjamin Funke, MD; Sebastian N. Eichberger, BS; Ziya Kaya, MD; Sebastian Buss, MD; Frank Autschbach, MD; Sven T. Pleger, MD; Ivan K. Lukic, MD, PhD; Florian Bea, MD; Stefan E. Hardt, MD; Per M. Humpert, MD; Marco E. Bianchi, PhD; Heimo Mairbäurl, PhD; Peter P. Nawroth, MD; Andrew Remppis, MD; Hugo A. Katus, MD^*; Angelika Bierhaus, PhD^*

From the Department of Medicine III (M.A., H.C.V., J.C.I., S.N.E., Z.K., S.B., S.T.P., F.B., S.E.H., A.R., H.A.K.), Institute of Pathology (B.F., F.A.), Department of Medicine I and Clinical Chemistry (I.K.L., P.M.H., P.P.N., A.B.), and Department of Medicine VII (H.M.), University of Heidelberg, Heidelberg, Germany, and San Raffaele University, Chromatin Dynamics Unit, Milan, Italy (M.E.B.).

Correspondence to Dr Angelika Bierhaus, Department of Medicine I and Clinical Chemistry, University of Heidelberg, INF 410, 69120 Heidelberg, Germany. E-mail angelika.bierhaus{at}med.uni-heidelberg.de

Received October 4, 2007; accepted April 7, 2008.

Background— High-mobility group box-1 (HMGB1) is a nuclear factor released by necrotic cells and by activated immune cells. HMGB1 signals via members of the toll-like receptor family and the receptor for advanced glycation end products (RAGE). Although HMGB1 has been implicated in ischemia/reperfusion (I/R) injury of the liver and lung, its role in I/R injury of the heart remains unclear.

Methods and Results— Here, we demonstrate that HMGB1 acts as an early mediator of inflammation and organ damage in I/R injury of the heart. HMGB1 levels were already elevated 30 minutes after hypoxia in vitro and in ischemic injury of the heart in vivo. Treatment of mice with recombinant HMGB1 worsened I/R injury, whereas treatment with HMGB1 box A significantly reduced infarct size and markers of tissue damage. In addition, HMGB1 inhibition with recombinant HMGB1 box A suggested an involvement of the mitogen-activated protein kinases jun N-terminal kinase and extracellular signal-regulated kinase 1/2, as well as the nuclear transcription factor nuclear factor-B in I/R injury. Interestingly, infarct size and markers of tissue damage were not affected by administration of recombinant HMGB1 or HMGB1 antagonists in RAGE^–/– mice, which demonstrated significantly reduced damage in reperfused hearts compared with wild-type mice. Coincubation studies using recombinant HMGB1 in vitro induced an inflammatory response in isolated macrophages from wild-type mice but not in macrophages from RAGE^–/– mice.

Conclusions— HMGB1 plays a major role in the early event of I/R injury by binding to RAGE, resulting in the activation of proinflammatory pathways and enhanced myocardial injury. Therefore, blockage of HMGB1 might represent a novel therapeutic strategy in I/R injury.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 117: 3161-3162. [Full Text]

This article has been cited by other articles:

				R. Ramasamy, S. F. Yan, and A. M. Schmidt Stopping the Primal RAGE Reaction in Myocardial Infarction: Capturing Adaptive Responses to Heal the Heart? Circulation, June 24, 2008; 117(25): 3165 - 3167. [Full Text] [PDF]